Welcome to the 2020 Exhibitor Hub!
Virtual Exhibit Hall
$10,000 Corporate Members
|
|
Merck
www.merck.com Representative Mark Montello [email protected] 603-321-1145 Click here to enter the Merck Zoom Room. |
|
|
Janssen Oncology
www.janssen.com/oncology Representative Peter Orrok [email protected] 267-733-3020 Click here to learn more about our products. Watch Now: Janssen 2019 U.S. Transparency Report: 3 Things to Know Click here to enter the Janssen Oncology Zoom Room. |
|
|
Immunomedics
www.immunomedics.com Representatives Stephen Gardner, Oncology Account Manager [email protected] Jim McDermott [email protected] Click here to enter the Immunomedics Zoom Room. Passcode: 493945 |
$5,000 Corporate Members
|
|
Sanofi Genzyme
www.sarclisaHCP.com www.sanofigenzymeoncology-ourproducts.com Representatives Michael McDonald [email protected] 215-205-9773 Joe Strzelecki [email protected] 215-570-4898 Amy Wascura [email protected] Nanette Rutherford [email protected] |
|
|
Pfizer Oncology
www.pfizer.com/oncology www.pfizeroncologycongressresources.com/OBU Representative Susan Sproat, Field Reimbursement Manager [email protected] |
|
Astellas
www.astellas.com Representatives Eric Tucker [email protected] Mark Deleo [email protected] Kristen Sichler [email protected] |
|
Seattle Genetics
www.seattlegenetics.com Representatives Jim Turconi [email protected] Alyssa Levensten [email protected] Kathy Cruz [email protected] TUKYSA (tucatinib) tablets Prescribing Information. ADCETRIS (brentuximab vedotin) for injection Prescribing Information, including BOXED WARNING |
Gold Exhibitor
|
|
Deciphera
www.deciphera.com Representatives Cara Hlushak, Oncology Territory Manager, Philadelphia [email protected] John Rensel [email protected] QINLOCK™ (ripretinib) Management Brochure QINLOCK™ (ripretinib) Product Fact Sheet |
Silver Exhibitors
|
|
Incyte Corporation
www.incyte.com Representatives Wendy Keim, Oncology Therapeutic Specialist [email protected] 570-492-0621 Phillip Holloway, Oncology Account Specialist [email protected] 215-740-8816 Dave Moore, Oncology Therapeutic Specialist [email protected] 757-513-7730 Lisa McLain, Oncology Account Specialist [email protected] 412-310-7030 Mitch Mensh [email protected] Monjuvi (tafasitamab-cxix) information Pemazyre Full Prescribing Information Pemazyre now approved Jakafi Information Jakafi Prescribing Information Insurance and Financial Assistance for Eligible Patients Prescribed Jakafi (ruxolitinib) |
|
|
BeiGene
www.beigene.com www.brukinsa.com/hcp Representatives Carl Majeski, Account Manager Hematology [email protected] Keli Frentzos, Account Manager Hematology [email protected] Darren Sand, Account Manager Hematology [email protected] Alicia Wasdworth, Account Manager Hematology [email protected] BeiGene is also hosting a non-CME Product Showcase titled "Discussion of Brukinsa™ For Adult Patients With Mantle Cell Lymphoma (MCL) Who Have Received At Least One Prior Therapy" at 11:45 AM on September 25. Learn more about the product showcase and enter the presentation here. |
|
|
|
|
Pharmacyclics
www.imbruvicahcp.com Representative Cara Reinard [email protected] IMBRUVICA Information IMBRUVICA Prescribing Information Clinical Information 1 Clinical Information 2 Clinical Information 3 IMBRUVICA Patient Support |
|
|
Lilly
www.syneoshealth.com Representatives Sarah Blasser [email protected] 717-578-6159 Jason Wiener [email protected] 215-873-4925 For more information regarding Lilly products, please call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979) or email [email protected]. To request a Lilly sales representative visit https://www.lilly.com/resources/lilly-answers-center |
